Predictive ability of a semi-mechanistic model for neutropenia in the development of novel anti-cancer agents: two case studies

In cancer chemotherapy neutropenia is a common dose-limiting toxicity. An ability to predict the neutropenic effects of cytotoxic agents based on proposed trial designs and models conditioned on previous studies would be valuable. The aim of this study was to evaluate the ability of a semi-mechanist...

Descripción completa

Detalles Bibliográficos
Autores principales: Soto, Elena, Keizer, Ron J., Trocóniz, Iñaki F., Huitema, Alwin D. R., Beijnen, Jos H., Schellens, Jan H. M., Wanders, Jantien, Cendrós, Josep María, Obach, Rosendo, Peraire, Concepción, Friberg, Lena E., Karlsson, Mats O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2010
Materias:
Phase I Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160557/
https://www.ncbi.nlm.nih.gov/pubmed/20449627
http://dx.doi.org/10.1007/s10637-010-9437-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160557/
https://www.ncbi.nlm.nih.gov/pubmed/20449627
http://dx.doi.org/10.1007/s10637-010-9437-z

Ejemplares similares